The optimal control system of the ship based on the linear quadratic regular algorithm

In this paper, the authors propose an optimal controller for the ship motion. Firstly, the model and dynamic equations of the ship motion are presented. Based on the model of the ship motion, the authors build the linear quadratic regular algorithm-based control system of ship motion to minimize the error between the desired trajectory and the response trajectory. The task of the controller is to control the trajectory of the ship to coincide with the desired trajectory. The ship model and controller are built to investigate the system quality through Matlab-Simulink software. The results show that the quality of the hold control system is very high. The trajectory of a ship always follows the desired trajectory with very small errors

An Updated Loop-Mediated Isothermal Amplification Method for Rapid Diagnosis of H5N1 Avian Influenza Viruses

We designed a new set of primers for reverse transcriptase loop-mediated isothermal amplification (RTLAMP) to specifically amplify the HA gene of avian influenza viruses subtype H5N1. By testing nine H5N1 virus strains and 41 clinical samples collected in Northern Vietnam, we found that the new primers showed higher sensitivity and specificity than the previously published RT-LAMP primers and were comparable to the RT-PCR method currently recommended by WHO. These results suggest that our RT-LAMP assay may be a better choice as a diagnostic tool for current H5N1 influenza virus infection

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke

Fe3O4/Reduced Graphene Oxide Nanocomposite: Synthesis and Its Application for Toxic Metal Ion Removal

The synthesis of reduced graphene oxide modified by magnetic iron oxide (Fe3O4/rGO) and its application for heavy metals removal were demonstrated. The obtained samples were characterized by X-ray diffraction (XRD), nitrogen adsorption/desorption isotherms, X-ray photoelectron spectroscopy (XPS), Fourier transform infrared spectroscopy (FT-IR), and magnetic measurement. The results showed that the obtained graphene oxide (GO) contains a small part of initial graphite as well as reduced oxide graphene. GO exhibits very high surface area in comparison with initial graphite. The morphology of Fe3O4/rGO consists of very fine spherical iron nanooxide particles in nanoscale. The formal kinetics and adsorption isotherms of As(V), Ni(II), and Pb(II) over obtained Fe3O4/rGO have been investigated. Fe3O4/rGO exhibits excellent heavy metal ions adsorption indicating that it is a potential adsorbent for water sources contaminated by heavy metals

Electrochemical Determination of Paracetamol Using Fe 3

The synthesis of magnetic iron oxide/reduced graphene oxide (Fe3O4/rGO) and its application to the electrochemical determination of paracetamol using Fe3O4/rGO modified electrode were demonstrated. The obtained materials were characterized by means of X-ray diffraction (XRD), nitrogen adsorption/desorption isotherms, X-ray photoelectron spectroscopy (XPS), transmission electron microscope (TEM), Fourier transform infrared spectroscopy (FTIR), and magnetic measurement. The results showed that Fe3O4/rGO composite exhibited high specific surface area, and its morphology consists of very fine spherical particles of Fe3O4 in nanoscales. Fe3O4/rGO was used as an electrode modifier for the determination of paracetamol by differential pulse-anodic stripping voltammetry (DP-ASV). The preparation of Fe3O4/rGO-based electrode and some factors affecting voltammetric responses were investigated. The results showed that Fe3O4/rGO is a potential electrode modifier for paracetamol detection by DP-ASV with a low limit of detection. The interfering effect of uric acid, ascorbic acid, and dopamine on the current response of paracetamol has been reported. The repeatability, reproducibility, linear range, and limit of detection were also addressed. The proposed method could be applied to the real samples with satisfactory results

Low-Dimensional CsPbBr₃@CoBr₂ Super-Nanowire Structure for Perovskite/PMMA Composite with Highly Blue Emissive Performance

In this study, low-dimensional CsPbBr3@CoBr2 super-nanowire (SNW) structures were synthesized via a one-pot heating strategy for highly blue emissions. By introducing CoBr2 to CsPbBr3 precursors, the shape of perovskite nanocrystals was changed from cuboids to a super-nanowire structure, as revealed through a transmission electron microscope. SNWs were formed from stacked segments of nano-plates (lateral dimension of 10–12 nm and thickness of ~2.5 nm) with lengths of several microns. The fabricated sample absorbs light at a wavelength of 3@CoBr2 SNWs highly promising for a range of photolumicescence applications, such as a high color rendering index lighting and transparent blue emissive screen